COMMUNIQUÉS West-GlobeNewswire

-
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis
20/09/2019 -
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère
20/09/2019 -
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0475 Per Share
20/09/2019 -
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
20/09/2019 -
FDA approves cobas Babesia, Roche’s first whole blood test for donor screening
20/09/2019 -
IBA subsidiary, Normandy Hadrontherapy, launches development of carbon therapy system in Normandy, France
20/09/2019 -
Normandy Hadrontherapy, filiale d'IBA, lance le développement d'un système de traitement par carbone en Normandie, en France
20/09/2019 -
InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering
20/09/2019 -
XORTX Announces Positive Phase 2 Results in Type 2 Diabetic Nephropathy (T2DN)
20/09/2019 -
Psychemedics Corporation Announces New Brazilian Distribution Agreement
19/09/2019 -
CV Sciences, Inc. Announces Plans to File Request For Continued Examination of Its US Patent Application
19/09/2019 -
Align Technology Announces Global Distribution Agreement With Zimmer Biomet Dental For Itero Element® Intraoral Scanners
19/09/2019 -
Globus Medical Showcases Latest Innovations at NASS 2019
19/09/2019 -
Prevail Therapeutics Announces Addition to Russell 2000®, 3000® and Microcap® Indexes
19/09/2019 -
Kiniksa Presents Preclinical Data Supporting KPL-716 Clinical Development at the 49th Annual Meeting of the European Society of Dermatological Research
19/09/2019 -
HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock
19/09/2019 -
Galapagos increases share capital through warrant exercises
19/09/2019 -
Transparency notification
19/09/2019 -
Monthly information regarding the total number of voting rights and total number of shares of the Company
19/09/2019
Pages